Google-backed Isomorphic raises $2.1 billion to scale AI-driven drug discovery
Isomorphic Labs secured $2.1 billion in funding led by Thrive Capital to expand its AI-driven drug discovery platform. The company aims to begin clinical trials by the end of 2026 using its AlphaFold-
reuters · 2026-05-12 08:22